NEGIRI protokol - DBCG
NEGIRI protokol - DBCG
NEGIRI protokol - DBCG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Horisberger K, Erben P, Muessle B et al. Topoisomerase I expression correlates to<br />
response to neoadjuvant irinotecan-based chemoradiation in rectal cancer. Anticancer<br />
Drugs 2009; 20: 519-24.<br />
Recist<br />
En fase II-undersøgelse af irinotecan ugentligt til patienter med lokal avanceret eller metastatiskHER 2<br />
negativ brystkræft og øget antal kopier af topoisomerase 1(TOP1) genet.<br />
Protokol version 16. maj 2013, amendment nr. 2<br />
Forsøget er godkendt af Lægemiddelstyrelsen Eudract nr.: 2012-002348-26 og<br />
Den Videnskabsetiske Komite, nr.: H-1-2012-066<br />
41<br />
Therasse, P., et al. "New guidelines to evaluate the response to treatment in solid<br />
tumors. European Organization for Research and Treatment of Cancer, National Cancer<br />
Institute of the United States, National Cancer Institute of Canada." J Natl Cancer Inst<br />
2000; 92: 205-16.<br />
Eisenhaue EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid<br />
tumors: revised RECIST guideline (version1.1). Eur J Cancer 2009; 45: 228-47.
Change language